Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice

M. Hensler, K. Bardova, ZM. Jilkova, W. Wahli, D. Meztger, P. Chambon, J. Kopecky, P. Flachs,

. 2011 ; 10 () : 128. [pub] 20110802

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

BACKGROUND: Long-chain n-3 polyunsaturated fatty acids (LC n-3 PUFA) of marine origin exert multiple beneficial effects on health. Our previous study in mice showed that reduction of adiposity by LC n-3 PUFA was associated with both, a shift in adipose tissue metabolism and a decrease in tissue cellularity. The aim of this study was to further characterize the effects of LC n-3 PUFA on fat cell proliferation and differentiation in obese mice. METHODS: A model of inducible and reversible lipoatrophy (aP2-Cre-ERT2 PPARγL2/L2 mice) was used, in which the death of mature adipocytes could be achieved by a selective ablation of peroxisome proliferator-activated receptor γ in response to i.p. injection of tamoxifen. Before the injection, obesity was induced in male mice by 8-week-feeding a corn oil-based high-fat diet (cHF) and, subsequently, mice were randomly assigned (day 0) to one of the following groups: (i) mice injected by corn-oil-vehicle only, i.e."control" mice, and fed cHF; (ii) mice injected by tamoxifen in corn oil, i.e. "mutant" mice, fed cHF; (iii) control mice fed cHF diet with15% of dietary lipids replaced by LC n-3 PUFA concentrate (cHF+F); and (iv) mutant mice fed cHF+F. Blood and tissue samples were collected at days 14 and 42. RESULTS: Mutant mice achieved a maximum weight loss within 10 days post-injection, followed by a compensatory body weight gain, which was significantly faster in the cHF as compared with the cHF+F mutant mice. Also in control mice, body weight gain was depressed in response to dietary LC n-3 PUFA. At day 42, body weights in all groups stabilized, with no significant differences in adipocyte size between the groups, although body weight and adiposity was lower in the cHF+F as compared with the cHF mice, with a stronger effect in the mutant than in control mice. Gene expression analysis documented depression of adipocyte maturation during the reconstitution of adipose tissue in the cHF+F mutant mice. CONCLUSION: Dietary LC n-3 PUFA could reduce both hypertrophy and hyperplasia of fat cells in vivo. Results are in agreement with the involvement of fat cell turnover in control of adiposity.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12028134
003      
CZ-PrNML
005      
20121207122927.0
007      
ta
008      
120817e20110802enk f 000 0#eng||
009      
AR
024    7_
$a 10.1186/1476-511x-10-128 $2 doi
035    __
$a (PubMed)21810216
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Hensler, Michal $u Department of Adipose Tissue Biology, Institute of Physiology Academy of Sciences of Czech Republic v.v.i., Prague, Czech Republic.
245    14
$a The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice / $c M. Hensler, K. Bardova, ZM. Jilkova, W. Wahli, D. Meztger, P. Chambon, J. Kopecky, P. Flachs,
520    9_
$a BACKGROUND: Long-chain n-3 polyunsaturated fatty acids (LC n-3 PUFA) of marine origin exert multiple beneficial effects on health. Our previous study in mice showed that reduction of adiposity by LC n-3 PUFA was associated with both, a shift in adipose tissue metabolism and a decrease in tissue cellularity. The aim of this study was to further characterize the effects of LC n-3 PUFA on fat cell proliferation and differentiation in obese mice. METHODS: A model of inducible and reversible lipoatrophy (aP2-Cre-ERT2 PPARγL2/L2 mice) was used, in which the death of mature adipocytes could be achieved by a selective ablation of peroxisome proliferator-activated receptor γ in response to i.p. injection of tamoxifen. Before the injection, obesity was induced in male mice by 8-week-feeding a corn oil-based high-fat diet (cHF) and, subsequently, mice were randomly assigned (day 0) to one of the following groups: (i) mice injected by corn-oil-vehicle only, i.e."control" mice, and fed cHF; (ii) mice injected by tamoxifen in corn oil, i.e. "mutant" mice, fed cHF; (iii) control mice fed cHF diet with15% of dietary lipids replaced by LC n-3 PUFA concentrate (cHF+F); and (iv) mutant mice fed cHF+F. Blood and tissue samples were collected at days 14 and 42. RESULTS: Mutant mice achieved a maximum weight loss within 10 days post-injection, followed by a compensatory body weight gain, which was significantly faster in the cHF as compared with the cHF+F mutant mice. Also in control mice, body weight gain was depressed in response to dietary LC n-3 PUFA. At day 42, body weights in all groups stabilized, with no significant differences in adipocyte size between the groups, although body weight and adiposity was lower in the cHF+F as compared with the cHF mice, with a stronger effect in the mutant than in control mice. Gene expression analysis documented depression of adipocyte maturation during the reconstitution of adipose tissue in the cHF+F mutant mice. CONCLUSION: Dietary LC n-3 PUFA could reduce both hypertrophy and hyperplasia of fat cells in vivo. Results are in agreement with the involvement of fat cell turnover in control of adiposity.
650    _2
$a tukové buňky $x účinky léků $x patologie $7 D017667
650    _2
$a zvířata $7 D000818
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a kukuřičný olej $x škodlivé účinky $7 D003314
650    _2
$a preklinické hodnocení léčiv $7 D004353
650    _2
$a epididymis $x metabolismus $x patologie $7 D004822
650    _2
$a omega-3 mastné kyseliny $x farmakologie $7 D015525
650    _2
$a exprese genu $7 D015870
650    _2
$a genový knockout $7 D055786
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a myši transgenní $7 D008822
650    _2
$a obezita $x chemicky indukované $x prevence a kontrola $7 D009765
650    _2
$a PPAR alfa $x genetika $x metabolismus $7 D047493
650    _2
$a PPAR gama $x genetika $7 D047495
650    _2
$a cyklooxygenasy $x genetika $x metabolismus $7 D011451
650    _2
$a proteiny $x genetika $x metabolismus $7 D011506
650    _2
$a stearyl-CoA-desaturasa $x genetika $x metabolismus $7 D013230
650    _2
$a trans-aktivátory $x genetika $x metabolismus $7 D015534
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bardova, Kristina
700    1_
$a Jilkova, Zuzana Macek
700    1_
$a Wahli, Walter
700    1_
$a Meztger, Daniel
700    1_
$a Chambon, Pierre
700    1_
$a Kopecky, Jan
700    1_
$a Flachs, Pavel
773    0_
$w MED00008241 $t Lipids in health and disease $x 1476-511X $g Roč. 10(20110802), s. 128
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21810216 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120817 $b ABA008
991    __
$a 20121207123001 $b ABA008
999    __
$a ok $b bmc $g 950176 $s 785480
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 10 $d 128 $e 20110802 $i 1476-511X $m Lipids in health and disease $n Lipids Health Dis $x MED00008241
LZP    __
$a Pubmed-20120817/11/04

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...